In those patients fulfilling the criteria suggestive of chronic, irreversible sinonasal pathology, primary endoscopic radical antrectomy was significantly better than endoscopic middle meatal antrostomy, based on subjective and objective findings.
Background:The lower limb peripheral arterial disease (PAD) is the third-largest atherosclerotic disease site along with heart disease and cerebrovascular disease, a condition that was often overlooked in the past, but which has been a growing cause of Cardiovascular Disability and Mortality, in recent years. Aim of work: Assessment of the results of hybrid procedures using Endovascular and open techniques for surgery simultaneously, in patients with critical lower limb ischemia caused by arterial multilevelocclusive disease, as regards to patency as well as the complications.Patient and Methods: This randomized study was conducted on 40 patients attending at Al-Azhar University Hospitals with arterial multisegmental lesionsaffecting lower limbs. They all treated with hybrid techniques. Results: Technical success in 93.22% (55 of 59) of the procedures.The pre-intervention mean ABPI for the 40 patients was 0.32 ± 0.04, which improved to 0.70 ± 0.15 immediately post-intervention (P<0.01).The primary rate of patency at 12 months was 72.5%. The cumulative limb salvage rate at 12 months was 77.5% (standard error: <10%). It was seven major and ten minor complications in the perioperative period for an overall rate of 27.5%. Mortality occurred in two patients (5%). Conclusion: the hybrid procedures of this high-risk group of patients can simplify the management of multilevel PAD and optimize limb salvage while minimizing total patient risk.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.